Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Aspen Neuroscience Inc.
ASPE · News
website
117
Aspen Neuroscience, Inc. is a clinical-stage regenerative medicine biotechnology company, which enga...
Price
12.4
Market Cap
494.75 M
Float
3.79 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about ASPE
Aspen Neuroscience Inc.
ASPE · News
3.79 M
Float
12.4
Price
494.75 M
Market Cap
FEATURED
Aspen Neuroscience Announces Pricing of Initial Public Offering
SAN DIEGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Aspen Neuroscience, Inc. (NASDAQ:ASPE), a clinical-stage regenerative medicine biotechnology company developing autologous cell therapies for Parkinson’s disease (PD),
Summary
Oct 29, 2026, 10:12 PM
·
Globe Newswire
